Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002744

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 27, 2016
Accepted (ET)
Mar 29, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 23, 2016P400$2.14A2,113,182ISee footnote
Common StockF3Aug 23, 2016P400$2.14A1,587,299D
Common StockF1,F2Aug 31, 2016P1,600$2.12A2,114,782ISee footnote
Common StockF3Aug 31, 2016P1,600$2.12A1,588,899D
Common StockF1,F2Aug 31, 2016P11,100$2.01A2,125,882ISee footnote
Common StockF3Aug 31, 2016P11,100$2.01A1,599,999D
Common StockF1,F2Sep 21, 2016P100$2.11A2,125,982ISee footnote
Common StockF3Sep 21, 2016P100$2.11A1,600,099D
Common StockF1,F2Sep 29, 2016P7,000$2.06A2,132,982ISee footnote
Common StockF3Sep 29, 2016P7,000$2.06A1,607,099D
Common StockF1,F2Sep 30, 2016P5,000$2.09A2,137,982ISee footnote
Common StockF3Sep 30, 2016P5,000$2.09A1,612,099D
Common StockF1,F2Oct 28, 2016P1,000$2.04A2,138,982ISee footnote
Common StockF3Oct 28, 2016P1,000$2.04A1,613,099D
Common StockF1,F2Nov 3, 2016P1,000$2.02A2,139,982ISee footnote
Common StockF3Nov 3, 2016P1,000$2.02A1,614,099D
Common StockF1,F2Nov 15, 2016P2,000$1.87A2,141,982ISee footnote
Common StockF3Nov 15, 2016P2,000$1.87A1,616,099D
Common StockF1,F2Dec 16, 2016P5,000$2.00A2,146,982ISee footnote
Common StockF3Dec 16, 2016P5,000$2.00A1,621,099D
Common StockF1,F2Dec 28, 2016P9,500$1.88A2,156,482ISee footnote
Common StockF3Dec 28, 2016P9,500$1.88A1,630,599D
Common StockF1,F2Dec 29, 2016P2,000$2.21A2,158,482ISee footnote
Common StockF3Dec 29, 2016P2,000$2.21A1,632,599D
Common StockF1,F2Dec 29, 2016P2,000$1.97A2,160,482ISee footnote
Common StockF3Dec 29, 2016P2,000$1.97A1,634,599D
Common StockF1,F2Dec 30, 2016P100$2.34A2,160,582ISee footnote
Common StockF3Dec 30, 2016P100$2.34A1,634,699D
Common StockF1,F2Dec 30, 2016P200$2.13A2,160,782ISee footnote
Common StockF3Dec 30, 2016P200$2.13A1,634,899D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

This is the second part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.